Direct Refolding of Recombinant Human Growth Differentiation Factor 5 for Large-Scale Production Process
スポンサーリンク
概要
- 論文の詳細を見る
An efficient downstream process for the production of recombinant human growth differentiation factor 5(rhGDF5) has been developed for industrial application utilizing a novel "direct refolding" method. In this method, the starting material is an inclusion body produced in Escherichia coli, and the critical step is the direct refolding step that follows directly after solubilization of the inclusion body. rhGDF5 can be refolded at a markedly high concentration of 2.4 mg・ml^<-1> which is 24 times that hitherto achieved by the proteins of the TGF-β superfamily. The refolding yield is 63%, and after purification by diafiltration, isoelectric precipitation and reverse-phase chromatography, the final purification yield is 20% with purity higher than 99%. The yield is more than twice that of a conventionally established process having three chromatography steps and the purity is equivalent. The first pilot-scale trial shows a refolding yield of 51% and a final yield of 11%. The final yield is 1.4 times that of the conventional process, and further optimization at pilot-scale is expected to bring this figure up to or above that of laboratory-scale. As a result, the calculated production cost of rhGDF5 has been reduced dramatically. This type of efficient and simple process is beneficial particularly in the large-scale production of recombinant proteins in which high yield and quality are required.
- 公益社団法人日本生物工学会の論文
- 2000-06-25
著者
-
Honda Jun
Bio-process Development Center Aventis Pharma Ltd.
-
SUGIMOTO SHUNJIRO
Bio-process Development Center, Aventis Pharma Ltd.
-
Sugimoto S
Laboratory Of Microbial Technology Division Of Microbial Science And Technology Department Of Biosci
-
Mannen Teruhisa
Department Of Chemistry And Biotechnology Graduate School Of Engineering The University Of Tokyo
-
ANDOU HIDETOSHI
Bio-process Development Center, Aventis Pharma Ltd.
-
MANNEN TERUHISA
Bio-process Development Center, Aventis Pharma Ltd.
-
Andou Hidetoshi
Bio-process Development Center Aventis Pharma Ltd.
関連論文
- Reconstitution and Function of Tetragenococcus halophila Chaperonin 60 Tetradecamer(Genetics, Molecular Biology, and Gene Engineering)
- Effect of Heterologous Expression of Molecular Chaperone DnaK from Tetragenococcus halophilus on Salinity Adaptation of Escherichia coli(MICROBIAL PHYSIOLOGY AND BIOTECHNOLOGY)
- Molecular Characterization and Regulatory Analysis of dnaK Operon of Halophilic Lactic Acid Bacterium Tetragenococcus halophila
- Expanded-Bed Protein Refolding Using a Solid-Phase Artificial Chaperone
- Monitoring of the Refolding Process for Immobilized Firefly Luciferase with a Biosensor Based on Surface Plasmon Resonance
- In Vivo and in Vitro Complementation Study Comparing the Function of DnaK Chaperone Systems from Halophilic Lactic Acid Bacterium Tetragenococcus halophilus and Escherichia coli
- Direct Refolding of Recombinant Human Growth Differentiation Factor 5 for Large-Scale Production Process